Popular Trials
Cholinesterase Inhibitor
Pyridostigmine for Postural Tachycardia Syndrome
Recruiting0 awardsPhase 2
Rochester, Minnesota
This trial will compare the effects of pyridostigmine to placebo in treating postural tachycardia syndrome. The researchers expect that pyridostigmine will improve tachycardia and stabilize blood pressure.
Small Molecule Kinase Inhibitor
HKI-272 for Breast Cancer
Recruiting1 awardPhase 2
Rochester, Minnesota
This trial will test how well neratinib works in treating breast cancer that has spread to the brain. Neratinib is a drug that may stop breast cancer cells from growing by inhibiting proteins that include HER2. The trial will look at how well neratinib works to decrease the size of or stabilize breast cancer in the brain, and also how it affects thinking and how much neratinib reaches the central nervous system.
Proteasome Inhibitor
Ixazomib for Multiple Myeloma
Recruiting1 awardPhase 2
Rochester, Minnesota
This trial study looks at the effects of ixazomib citrate on patients with multiple myeloma who have had a relapse, but are still responsive to bortezomib. Ixazomib citrate may prevent cancer cell growth by blocking some of the enzymes necessary for cell growth.
Popular Filters
Phase 3 Trials
Platinum-based Chemotherapy
Chemo-Radiation for Early-Stage Cervical Cancer
Recruiting2 awardsPhase 3
Minneapolis, Minnesota
This trial is studying how well giving chemotherapy and pelvic radiation therapy together with or without additional chemotherapy works in treating patients with high-risk early-stage cervical cancer.
Alkylating agents
Combination Chemotherapy for Ewing's Sarcoma
Recruiting4 awardsPhase 3
Minneapolis, Minnesota
This trial is studying different combination chemotherapy regimens to see how well they work when given with or without peripheral stem cell transplantation, radiation therapy, and/or surgery in treating patients with Ewing's sarcoma.
Janus Kinase (JAK) Inhibitor
Tofacitinib for Juvenile Arthritis
Recruiting1 awardPhase 2 & 3
Minneapolis, Minnesota
This trial will evaluate the long-term safety and tolerability of tofacitinib in patients with juvenile idiopathic arthritis (JIA) who have previously participated in tofacitinib JIA studies.
Trials With No Placebo
Platinum-based Chemotherapy
Chemo-Radiation for Early-Stage Cervical Cancer
Recruiting2 awardsPhase 3
Minneapolis, Minnesota
This trial is studying how well giving chemotherapy and pelvic radiation therapy together with or without additional chemotherapy works in treating patients with high-risk early-stage cervical cancer.
Alkylating agents
Surgery + Chemotherapy + IMRT for Mesothelioma
Recruiting1 awardPhase 2
Rochester, Minnesota
This trial is testing a new, safer radiation therapy for people with a certain type of lung cancer. The old radiation therapy had lots of side effects, but the new one specifically targets the cancer and reduces the risk of damaging healthy tissue.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.